Free Trial
CVE:DMT

Small Pharma (DMT) Stock Price, News & Analysis

Small Pharma logo
C$0.15 -0.01 (-6.25%)
(As of 10/20/2023)

About Small Pharma Stock (CVE:DMT)

Key Stats

Today's Range
C$0.15
C$0.16
50-Day Range
C$0.15
C$0.15
52-Week Range
C$0.06
C$0.22
Volume
1.89 million shs
Average Volume
296,159 shs
Market Capitalization
C$50.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Small Pharma Inc., a biotechnology company, focuses on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Its clinical program is based on N,N, dimethyltryptamine, a naturally occurring psychoactive molecule. The company's product includes SPL026, which is in clinical Phase IIa for the treatment of major depressive disorder; and SPL028, an injectable formulation of deuterated DMT, which is in Phase 1 clinical trial, as well as SPL801B, an oral dosage. Its preclinical stage programs include SPL029, an oral formulation of a tryptamine to treat depressive disorder. The company is headquartered in London, the United Kingdom. As of October 23, 2023, Small Pharma Inc. operates as a subsidiary of Cybin Inc.

Receive DMT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Small Pharma and its competitors with MarketBeat's FREE daily newsletter.

DMT Stock News Headlines

Milestone Pharmaceuticals Prepares for CARDAMYST Approval
Download Our Tesla Ebook For Free
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
LTR Pharma’s SPONTAN Nasal Spray Poised for Global Impact
See More Headlines

DMT Stock Analysis - Frequently Asked Questions

Small Pharma's stock was trading at C$0.15 on January 1st, 2024. Since then, DMT shares have increased by 0.0% and is now trading at C$0.15.
View the best growth stocks for 2024 here
.

Shares of DMT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Small Pharma investors own include Bombardier, Inc. Class B (BBD.B), Arrival (ARVL), Air Canada (AC), Beyond Meat (BYND), BioSig Technologies (BSGM), Aveanna Healthcare (AVAH) and Actinium Pharmaceuticals (ATNM).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

Net Income
C$-19,310,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$-1,162.00
Price / Sales
-43,343.80
Cash Flow
C$0.13 per share
Book Value
C$0.03 per share

Miscellaneous

Free Float
N/A
Market Cap
C$50.37 million
Optionable
Not Optionable
Beta
0.86
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (CVE:DMT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners